C. Tressler

发表

Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension

A. Laties, G. Burgess, B. Wirostko, 2012, BMJ : British Medical Journal.

Preservative use in topical glaucoma medications.

R. Beatty, M. Lemp, C. Tressler, 2011, The ocular surface.

Ocular Safety of Intravitreal Injections of Age-Related Macular Degeneration Treatments in a Prospective Observational Cohort Study in Europe

Kui Huang, C. Tressler, M. B. Sultan, 2015 .

Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature

B. Jessen, R. L. Wiseman, B. Wirostko, 2011, British Journal of Ophthalmology.

A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension

D. Eveleth, C. Starita, C. Tressler, 2012, BMC Ophthalmology.

Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.

Elizabeth E. Kim, E. Higginbotham, K. Kwok, 2010, Archives of ophthalmology.

Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: Findings of the PERSPECTIVES study

G. Staurenghi, R. Buggage, U. Chakravarthy, 2012, British Journal of Ophthalmology.

Effects of losartan on diabetic maculopathy in type 2 diabetic patients

G. Gleim, C. Tressler, 2004, Journal of internal medicine.

A 12-Week, Randomized, Double-Masked Study of Fixed Combination Latanoprost/Timolol versus Latanoprost or Timolol Monotherapy

Elizabeth E. Kim, P. Palmberg, K. Kwok, 2010, European journal of ophthalmology.

Practice patterns of ophthalmologists administering intravitreal injections in Europe: a longitudinal survey

Kui Huang, C. Tressler, M. B. Sultan, 2016, Clinical ophthalmology.

A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort Study.

R. Schachar, M. Klein, R. Platt, 2018, American journal of ophthalmology.

Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria

M. Hauben, C. Tressler, E. Hung, 2021, European Journal of Clinical Pharmacology.

Subconjunctival versus intrascleral mitomycin-C in trabeculectomy.

M. Cyrlin, C. Tressler, J. Rosenshein, 1996, Ophthalmic surgery and lasers.

Bimatoprost versus timolol and dorzolamide.

C. Tressler, 2005, Ophthalmology.

Letter to the Editor

C. Tressler, 2008 .

Results of a study comparing the stability, efficacy, and adverse effect profile of innovator formulation, latanoprost (Xalatan) ophthalmic solution 0.005%, with that of a new formulation of a latanoprost ophthalmic solution containing cyclodextrins.

C. Tressler, G. Bean, 2008, Journal of clinical pharmacology.